Clinical preparedness for severe pneumonia with highly pathogenic avian influenza A (H5N1): Experiences with cases in Vietnam

Respiratory Investigation

Volumn 50, Issue 4, 2012, Pages 140-150

  Kudo, Koichiro ^a,d   Binh, Nguyen Gia ^b   Manabe, Toshie ^a,d   Co, Dao Xuan ^b   Tuan, Nguyen Dang ^b   Izumi, Shinyu ^a   Takasaki, Jin ^a   Minh, Dang Hung ^b   Thuy, Pham Thi Phuong ^c   Van, Vu Thi Tuong ^b   Hanh, Tran Thuy ^b   Chau, Ngo Quy ^b  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b BACH MAI HOSPITAL   (Viet Nam)

^c NCGM BMH Medical Collaboration Center   (Viet Nam)

^d WASEDA UNIVERSITY   (Japan)

Author keywords

Acute respiratory distress syndrome; ALI; ARDS; Avian influenza; CHDF; Early intervention; FiO2; H5N1; IFN; IL; P F; PaO2; PMX; Polymyxin B immobilized hemoperfusion; SOFA; TNF

Indexed keywords

AMINOGLYCOSIDE; CARBAPENEM; CEPHALOSPORIN; CYTOKINE; HYDROCORTISONE; MACROLIDE; METHYLPREDNISOLONE; OSELTAMIVIR; POLYMYXIN B; TETRACYCLINE; TORAYMYXIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; AVIAN INFLUENZA; AVIAN INFLUENZA VIRUS; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONSULTATION; CONTINUOUS HEMODIAFILTRATION; DEMOGRAPHY; DISEASE SEVERITY; EPIDEMIC; FEMALE; HEMOPERFUSION; HOSPITALIZATION; HUMAN; LABORATORY TEST; MALE; ONSET AGE; OXYGENATION; PATIENT SURVIVAL; PNEUMONIA; POULTRY; PRESCHOOL CHILD; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SCHOOL CHILD; SURVIVAL; SURVIVOR; THERAPY DELAY; THORAX RADIOGRAPHY; VIET NAM;

ADOLESCENT; ADULT; ANIMALS; BIRDS; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; MALE; PNEUMONIA, VIRAL; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VIETNAM;

EID: 84870408806     PISSN: 22125345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resinv.2012.08.005     Document Type: Article

References (41)

1. World Health Organization. Cumulative number of confirmed human cases of avian influenza A (H5N1) reported to WHO. Available from: ; January 2012 [accessed January 30, 2012]. http://www.who.int/influenza/human_animal_interface/H5N1_cumulative_table_archives/en/index.html.
2. Adams S, Sandrock C Avian influenza: update. Med Princ Pract 2010, 19:421-432.
3. World Organization for Animal Health OIE daily update on avian influenza situation in birds. Available from: ; January 2012 [accessed January 30, 2012]. http://www.oie.int/animal-health-in-the-world/update-on-avian-influenza/2011/.
4. Hien TT, Liem NT, Dung NT, et al. The World Health Organization International Avian Influenza Investigative Team: avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med 2004, 350:1179-1188.
5. Avian influenza A (H5N1) infection in humans. N Engl J Med 2005, 353:1374-1385. The Writing Committee of the World Health Organization (WHO) Consultation on Human Influenza A/H5.
6. Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med 2008, 358:261-273. Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A (H5N1) Virus.
7. World Health Organization. Clinical management of human infection with avian influenza A (H5N1) virus. Available from: ; August 2007 [accessed January 10, 2011]. http://www.who.int/csr/disease/avian_influenza/guidelines/ClinicalManagement07.pdf.
8. Schünemann HJ, Hill SR, Kakad M, et al. WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus. Lancet Infect Dis 2007, 7:21-31.
9. Adisasmito W, Chan PKS, Lee N, et al. Effectiveness of antiviral treatment in human influenza A (H5N1) infections: analysis of a global patient registry. J Infect Dis 2010, 202:1154-1160.
10. White NJ, Webster RG, Govorkova EA, et al. What is the optimal therapy for patients with H5N1 influenza?. PLoS Med 2009, 6:e1000091.
11. Uyeki TM Human infection with highly pathogenic avian influenza A (H5N1) virus: review of clinical issues. Clin Infect Dis 2009, 49:279-290.
12. Kandun N, Tresnaningsih E, Purba WH, et al. Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case series. Lancet 2008, 372:744-749.
13. Bellomo R, Tipping P, Boyce N Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 1993, 21:522-526.
14. Hisataka S Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin). Ther Apher Dial 2003, 7:108-114.
15. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994, 149:818-824.
16. Pham ND, Hoang TL, Nguyen KT, et al. Risk factors for human infection with avian influenza A H5N1, Vietnam, 2004. Emerg Infect Dis 2006, 12:1841-1847.
17. Chotpitayasuondh T, Ungchusak K, Hanshaoworakul W, et al. Human disease from influenza A (H5N1), Thailand, 2004. Emerg Infect Dis 2005, 11:201-209.
18. Kandun IN, Wibisono H, Sedyaningsih ER, et al. Three Indonesian clusters of H5N1 virus infection in 2005. N Engl J Med 2006, 355:2186-2194.
19. Vong S, Ly S, Mardy S, et al. Environmental contamination during influenza A virus (H5N1) outbreaks, Cambodia, 2006. Emerg Infect Dis 2008, 14:1303-1305.
20. Keawcharoen J, van den Broek J, Bouma A, et al. Wild birds and increased transmission of highly pathogenic avian influenza (H5N1) among poultry, Thailand. Emerg Infect Dis 2011, 17:1016-1022.
21. World Health Organization Western Pacific Region. WHO representative office in Viet Nam speeches TET celebration. Available from: ; 2009 [accessed October 6, 2011]. http://www.wpro.who.int/vietnam/media_centre/speeches/speech_16012009.htm.
22. Magalhaes RJS, Oriz-Pelaez A, Kim LLT, et al. Associations between attributes of live poultry trade and HPAI H5N1 outbreaks: a descriptive and network analysis study in northern Vietnam. BMC Vet Res 2010, 6:10.
23. Le MTQ, Wertheim HFL, Nguyen HD, et al. Influenza A H5N1 Clade 2.3.4 Virus with a different antiviral susceptibility profile replaced Clade 1 Virus in humans in Northern Vietnam. PLoS ONE 2008, 3:e3339.
24. Liem NT, Tung CV, Hien ND, et al. Clinical features of human influenza A (H5N1) infection in Vietnam: 2004-2006. Clin Infect Dis 2009, 48:1639-1646.
25. Hien ND, Ha NH, Van NT, et al. Human infection with highly pathogenic avian influenza virus (H5N1) in northern Vietnam, 2004-2005. Emerg Infect Dis 2009, 15:19-23.
26. World Health Organization Update on human cases of highly pathogenic avian influenza A (H5N1) virus infection, 2010. Wkly Epidemiol Rec 2011, 86:161-166.
27. Manabe T, Thuy PTP, Can VV, et al. Impact of educational intervention concerning awareness and behaviors relating to Avian Influenza (H5N1) in a high-risk population in Vietnam. PLoS ONE 2011, 6:e23711.
28. Manabe T, Thuy PTP, Kudo K, et al. Impact of education and network for avian influenza H5N1 in human: knowledge, clinical practice, and motivation on medical providers in Vietnam. PLoS ONE 2012, 7:e30384.
29. Buchy P, Mardy S, Vong S, et al. Influenza A/H5N1 virus infection in human in Cambodia. J Clin Virol 2007, 39:164-168.
30. Cruz DN, Perazella MA, Bellomo R, et al. Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care 2007, 11:137.
31. Cruz DN, Antonelli M, Fumagalli R, et al. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 2009, 301:2445-2452.
32. Tsushima K, Koizumi T, Yoshikawa S, et al. Polymyxin B immobilized column is effective for hydrochloric acid induced lung injury in rats. Eur J Pharmacol 2006, 535:270-279.
33. Korteweg C, Gu J Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans. Am J Pathol 2008, 172:1155-1170.
34. Abe S, Seo Y, Hayashi H, et al. Neutrophil adsorption by polymyxin B-immobilized fiber column for acute exacerbation in patients with interstitial pneumonia: a pilot study. Blood Purif 2010, 29:321-326.
35. Kushi H, Miki T, Okamoro K, et al. Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation. Crit Care 2005, 9:R653-R661.
36. Mitaka C, Tomita M Polymyxin B-immobilized fiber column hemoperfusion therapy for septic shock. Shock 2011, 36:332-338.
37. Ruberto F, Pugliese F, D'Alio A, et al. Clinical effects of use polymyxin B fixed on fibers in liver transplant patients with severe sepsis or septic shock. Transplant Proc 2007, 39:1953-1955.
38. Yokoyama T, Tateishi K, Tsushima, et al. A case of severe ARDS caused by novel swine-origin influenza (A/H1N1pdm) virus: a successful treatment with direct hemoperfusion with polymyxin B-immobilized fiber. J Clin Apher 2010, 25:350-353.
39. Yatera K, Yamasaki K, Kawanami T, et al. A case of successful treatment with polymyxin B-immobilized fiber column direct hemoperfusion in acute respiratory distress syndrome after influenza A infection. Intern Med 2011, 50:601-605.
40. Takeda S, Munakata R, Abe S, et al. Hypercytokinemia with 2009 pandemic H1N1 (pH1N1) influenza successfully treated with polymyxin B-immobilized fiber column hemoperfusion. Intensive Care Med 2010, 36:906-907.
41. Suyama H, Kawasaki Y, Morikawa S, et al. Early induction of PMX-DHP improves oxygenation in severe sepsis patients with acute lung injury. Hiroshima J Med Sci 2008, 57:79-84.